Please login to the form below

Not currently logged in
Email:
Password:

Mitsubishi

This page shows the latest Mitsubishi news and features for those working in and with pharma, biotech and healthcare.

Mitsubishi buys Israel's NeuroDerm for $1.1bn

Mitsubishi buys Israel's NeuroDerm for $1.1bn

Japan's Mitsubishi Tanabe Pharma has boosted its pipeline with a $1.1bn deal to buy NeuroDerm, an Israeli developer of central nervous system therapies. ... Adding ND0612 into the portfolio will help Mitsubishi meet its target of driving US sales to 80bn

Latest news

More from news
Approximately 1 fully matching, plus 38 partially matching documents found.

Latest Intelligence

  • Deal Watch - May 2017 Deal Watch - May 2017

    It is not known why in December 2015 the territorial rights granted to Mitsubishi for vadadustat for treatment of anaemia, were limited to Japan, SE Asia and India.

  • Japanese pharma pulls no punches with post-Brexit UK Japanese pharma pulls no punches with post-Brexit UK

    The level of investment on the pharmaceutical side is considerable. The Japanese Pharmaceutical Group (JPG), an association of nine drugmakers - Astellas, Chugai, Daiichi-Sankyo, Eisai, Kowa, Mitsubishi Tanabe, Otsuka, Shionogi and

  • Deal Watch November 2016 Deal Watch November 2016

    generic company and distributor. acquisition - company. 462. Kolon Life Science | TissueGene / Mitsubishi.

  • Deal Watch October 2016 Deal Watch October 2016

    $203m. Mitsubishi Tanabe (JP) / Sept 15. Biogen (US). amiselimod / multiple sclerosis.

  • Deal Watch September 2016 Deal Watch September 2016

    India's Sun Pharmaceutical has partnered with Mitsubishi Tanabe Pharma to distribute and market 14 prescription drugs in Japan that Sun recently acquired from Novartis.

More from intelligence
Approximately 0 fully matching, plus 15 partially matching documents found.

Latest from PMHub

  • Swordfish Advertising

    Hospital speciality products. Ophthalmics. Mitsubishi Tanabe Pharma. Exembol. Norgine. MOVICOL. SETOFILM.

More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Anthill Agency

Anthill is a specialist digital agency and a strategic partner for life science companies....

Latest intelligence

Why heading online for scientific meetings can yield greater HCP engagement
Modern conferencing methods, with enhanced digital information transfers, offer unique opportunities for greater HCP engagement....
The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...
Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies
Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’s latest innovation in stem cell therapy and to learn his perspective on navigating the...

Infographics